IGHE and allergic asthma: For instance, they recommended anti-IgE therapy for allergic asthma, anti-IL-5 for eosinophilic asthma, and dupilumab as an option for eosinophilic or allergic asthma with frequent exacerbations, especially when maximal therapy has been reached (Cloutier et al., 2020).